-
1
-
-
84861827362
-
-
WHO. Accessed on 21 June
-
WHO. Accessed on 21 June, 2011. http://www.who.int/features/factfiles/cancer/en/index.html.
-
(2011)
-
-
-
3
-
-
79953305486
-
A melanoma molecular disease model
-
Vidwans S.J., Flaherty K.T., Fisher D.E., Tenenbaum J.M., Travers M.D., Shrager J. A melanoma molecular disease model. PloS One 2011, 6:e18257.
-
(2011)
PloS One
, vol.6
-
-
Vidwans, S.J.1
Flaherty, K.T.2
Fisher, D.E.3
Tenenbaum, J.M.4
Travers, M.D.5
Shrager, J.6
-
4
-
-
5444242604
-
An update on the genetics of colorectal cancer
-
Kemp Z., Thirlwell C., Sieber O., Silver A., Tomlinson I. An update on the genetics of colorectal cancer. Hum Mol Genet 2004, 13:R177-R185.
-
(2004)
Hum Mol Genet
, vol.13
-
-
Kemp, Z.1
Thirlwell, C.2
Sieber, O.3
Silver, A.4
Tomlinson, I.5
-
5
-
-
79958778350
-
The molecular biology of colorectal carcinoma and its implications: a review
-
Harrison S., Benziger H. The molecular biology of colorectal carcinoma and its implications: a review. Surg 2011, 9:200-210.
-
(2011)
Surg
, vol.9
, pp. 200-210
-
-
Harrison, S.1
Benziger, H.2
-
6
-
-
78650673521
-
Bioactive dehydrotyrosyl and dehydrodopyl compounds of marine origin
-
Sugumaran M., Robinson W.E. Bioactive dehydrotyrosyl and dehydrodopyl compounds of marine origin. Mar Drugs 2010, 8:2906-2935.
-
(2010)
Mar Drugs
, vol.8
, pp. 2906-2935
-
-
Sugumaran, M.1
Robinson, W.E.2
-
7
-
-
23944453589
-
Marine sponges as pharmacy
-
Sipkema D., Franssen M.C.R., Osinga R., Tramper J., Wijffels R.H. Marine sponges as pharmacy. Mar Biotechnol 2005, 7:142-162.
-
(2005)
Mar Biotechnol
, vol.7
, pp. 142-162
-
-
Sipkema, D.1
Franssen, M.C.R.2
Osinga, R.3
Tramper, J.4
Wijffels, R.H.5
-
8
-
-
3042617137
-
Advanced preclinical and clinical trials of natural products and related compounds from marine sources
-
Newman D.J., Cragg G.M. Advanced preclinical and clinical trials of natural products and related compounds from marine sources. Curr Med Chem 2004, 11:1693-1713.
-
(2004)
Curr Med Chem
, vol.11
, pp. 1693-1713
-
-
Newman, D.J.1
Cragg, G.M.2
-
9
-
-
33644764833
-
Synthesis and mass spectrometric analysis of cyclostellettamines H, I, K and L
-
Grube A., Timm C., Kock M. Synthesis and mass spectrometric analysis of cyclostellettamines H, I, K and L. Eur J Org Chem 2006, 1285-1295.
-
(2006)
Eur J Org Chem
, pp. 1285-1295
-
-
Grube, A.1
Timm, C.2
Kock, M.3
-
11
-
-
0343618731
-
Bioactive alkylpyridinium compounds from marine sponges
-
Sepcic K. Bioactive alkylpyridinium compounds from marine sponges. J Toxicol Toxin Rev 2000, 19:139-160.
-
(2000)
J Toxicol Toxin Rev
, vol.19
, pp. 139-160
-
-
Sepcic, K.1
-
12
-
-
33747172023
-
First total synthesis of the marine natural product viscosamine
-
Timm C., Kock M. First total synthesis of the marine natural product viscosamine. Synthesis-Stuttgart 2006, 2580-2584.
-
(2006)
Synthesis-Stuttgart
, pp. 2580-2584
-
-
Timm, C.1
Kock, M.2
-
13
-
-
76249124132
-
Marine natural products
-
Blunt J.W., Copp B.R., Munro M.H.G., Northcote P.T., Prinsep M.R. Marine natural products. Nat Prod Rep 2010, 27:165-237.
-
(2010)
Nat Prod Rep
, vol.27
, pp. 165-237
-
-
Blunt, J.W.1
Copp, B.R.2
Munro, M.H.G.3
Northcote, P.T.4
Prinsep, M.R.5
-
14
-
-
78650512859
-
Pyrinodemins E and F, new 3-alkylpyridine alkaloids from sponge Amphimedon sp
-
Kura K., Kubota T., Fromont J., Kobayashi J. Pyrinodemins E and F, new 3-alkylpyridine alkaloids from sponge Amphimedon sp. Bioorg Med Chem Lett 2011, 21:267-270.
-
(2011)
Bioorg Med Chem Lett
, vol.21
, pp. 267-270
-
-
Kura, K.1
Kubota, T.2
Fromont, J.3
Kobayashi, J.4
-
15
-
-
3142682334
-
Viscosaline: new 3-alkyl pyridinium alkaloid from the Arctic sponge Haliclona viscosa
-
Volk C.A., Kock M. Viscosaline: new 3-alkyl pyridinium alkaloid from the Arctic sponge Haliclona viscosa. Org Biomol Chem 2004, 2:1827-1830.
-
(2004)
Org Biomol Chem
, vol.2
, pp. 1827-1830
-
-
Volk, C.A.1
Kock, M.2
-
16
-
-
0024470099
-
Theonelladins A~D, novel antineoplasic pyridine alkaloids from the okinawan marine sponge Theonella-swinhoei
-
Kobayashi J., Murayama T., Ohizumi Y. Theonelladins A~D, novel antineoplasic pyridine alkaloids from the okinawan marine sponge Theonella-swinhoei. Tetrahedron Lett 1989, 30:4833-4836.
-
(1989)
Tetrahedron Lett
, vol.30
, pp. 4833-4836
-
-
Kobayashi, J.1
Murayama, T.2
Ohizumi, Y.3
-
17
-
-
4544243750
-
Synthesis of the unusual octahydropyrano 2,3-b pyridine ring system of upenamide
-
Maia A.A., Mons S., Gil R.P.D., Marazano C. Synthesis of the unusual octahydropyrano 2,3-b pyridine ring system of upenamide. Eur J Org Chem 2004, 1057-1062.
-
(2004)
Eur J Org Chem
, pp. 1057-1062
-
-
Maia, A.A.1
Mons, S.2
Gil, R.P.D.3
Marazano, C.4
-
18
-
-
80051586053
-
Synthesis and evaluation of antimalarial activity of oxygenated 3-alkylpyridine marine alkaloid analogues
-
Hilário F.F., de Paula R.C., Silveira M.L., Viana G.H.R., Alves R.B., Pereira J.R., et al. Synthesis and evaluation of antimalarial activity of oxygenated 3-alkylpyridine marine alkaloid analogues. Chem Bio Drug Des 2011, 78:477-482.
-
(2011)
Chem Bio Drug Des
, vol.78
, pp. 477-482
-
-
Hilário, F.F.1
de Paula, R.C.2
Silveira, M.L.3
Viana, G.H.R.4
Alves, R.B.5
Pereira, J.R.6
-
19
-
-
80053301623
-
Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment
-
Essack M., Bajic V.B., Archer J.A.C. Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment. Mar Drugs 2011, 9:1580-1606.
-
(2011)
Mar Drugs
, vol.9
, pp. 1580-1606
-
-
Essack, M.1
Bajic, V.B.2
Archer, J.A.C.3
-
20
-
-
39749163470
-
Analysis of apoptosis by cytometry using TUNEL assay
-
Darzynkiewicz Z., Galkowski D., Zhao H. Analysis of apoptosis by cytometry using TUNEL assay. Methods 2008, 44:250-254.
-
(2008)
Methods
, vol.44
, pp. 250-254
-
-
Darzynkiewicz, Z.1
Galkowski, D.2
Zhao, H.3
-
21
-
-
79960388676
-
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients
-
Correale P., Botta C., Basile A., Pagliuchi M., Licchetta A., Martellucci I., et al. Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients. Cancer Biol Ther 2011, 12:112-118.
-
(2011)
Cancer Biol Ther
, vol.12
, pp. 112-118
-
-
Correale, P.1
Botta, C.2
Basile, A.3
Pagliuchi, M.4
Licchetta, A.5
Martellucci, I.6
-
22
-
-
79960888214
-
Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells
-
Liu J., Uematsu H., Tsuchida N., Ikeda M.A. Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells. Mol Cancer 2011, 10:95.
-
(2011)
Mol Cancer
, vol.10
, pp. 95
-
-
Liu, J.1
Uematsu, H.2
Tsuchida, N.3
Ikeda, M.A.4
|